Terms: = Gastric cancer AND SETD2, ENSG00000181555, 29072 AND Treatment
4 results:
1. The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms.
Venizelos A; Elvebakken H; Perren A; Nikolaienko O; Deng W; Lothe IMB; Couvelard A; Hjortland GO; Sundlöv A; Svensson J; Garresori H; Kersten C; Hofsli E; Detlefsen S; Krogh M; Sorbye H; Knappskog S
Endocr Relat Cancer; 2021 Nov; 29(1):1-14. PubMed ID: 34647903
[TBL] [Abstract] [Full Text] [Related]
2. Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and gastric Adenocarcinoma.
Salem ME; Puccini A; Xiu J; Raghavan D; Lenz HJ; Korn WM; Shields AF; Philip PA; Marshall JL; Goldberg RM
Oncologist; 2018 Nov; 23(11):1319-1327. PubMed ID: 29866946
[TBL] [Abstract] [Full Text] [Related]
3. Effect of histone modifications on hMLH1 alternative splicing in gastric cancer.
Zhao JX; Li XW; Shi BY; Wang F; Xu ZR; Meng HL; Su YY; Wang JM; Xiao N; He Q; Wang YP; Fan YM
Tumour Biol; 2017 Apr; 39(4):1010428317697546. PubMed ID: 28381181
[TBL] [Abstract] [Full Text] [Related]
4. Epigenetic regulation of CDH1 exon 8 alternative splicing in gastric cancer.
Li XW; Shi BY; Yang QL; Wu J; Wu HM; Wang YF; Wu ZJ; Fan YM; Wang YP
BMC Cancer; 2015 Dec; 15():954. PubMed ID: 26674321
[TBL] [Abstract] [Full Text] [Related]